Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSU6162 in Fatigue After Aneurysmal Subarachnoid Hemorrhage
NCT03209830Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Sep 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in aneurysmal subarachnoid hemorrhage (SAH) comparing OSU6162 with Placebo (2 arms). Primary endpoint: Fatigue Severity Scale at 12 weeks. Started Sep 2017; status: completed.
02
Drugs
OSU-6162
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT03209830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03209830.